Nifty

:

24399.40

Sensex

:

80065.16

-36.10 (-0.15%)
-16.82 (-0.02%)

Login

Nifty
Sensex

:
:

24399.40
80065.16

-36.10 (-0.15%)
-16.82 (-0.02%)

Anuh Pharma Ltd.

Pharmaceuticals & Drugs - API

Rating :

N/A

BSE: 506260 | NSE: Not Listed

Watchlist

NSE BSE

192.45

24-Oct-2024

Open
High
Low
Previous Close

195.95
195.95
191.1
193.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

15128
2926477
265.00
124.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

964.41
16.77
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

956.75
1.30%
3.22

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.59
16.08
9.96

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.34
26.67
9.80

PAT CAGR (%)

10 Years
5 Years
3 Years

10.57
33.23
25.26

P:E (Median)

8 Years
5 Years
3 Years

20.00
18.90
16.79

P:BV (Average)

8 Years
5 Years
3 Years

2.97
2.97
2.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.81
12.10
10.69

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 137.91 161.48 -14.60% 163.89 157.31 4.18% 172.10 138.73 24.05% 149.53 115.07 29.95%
Expenses 127.34 147.51 -13.67% 144.67 143.08 1.11% 148.11 126.30 17.27% 131.57 101.64 29.45%
EBITDA 10.57 13.97 -24.34% 19.22 14.23 35.07% 23.99 12.43 93.00% 17.96 13.43 33.73%
EBIDTM 7.66% 8.65% 11.73% 9.05% 13.94% 8.96% 12.01% 11.67%
Other Income 3.72 3.47 7.20% 2.82 1.04 171.15% 3.66 2.11 73.46% 2.15 2.01 6.97%
Interest 0.14 0.02 600.00% 0.10 0.02 400.00% 0.14 0.03 366.67% 0.09 0.11 -18.18%
Depreciation 1.88 2.01 -6.47% 2.23 2.41 -7.47% 2.20 2.43 -9.47% 2.15 2.44 -11.89%
PBT 12.27 15.41 -20.38% 19.72 12.84 53.58% 25.30 12.08 109.44% 17.88 12.89 38.71%
Tax 2.76 3.66 -24.59% 4.36 3.22 35.40% 6.19 2.77 123.47% 4.04 2.97 36.03%
PAT 9.51 11.75 -19.06% 15.36 9.62 59.67% 19.11 9.31 105.26% 13.83 9.92 39.42%
PATM 6.89% 7.28% 9.37% 6.12% 11.11% 6.71% 9.25% 8.62%
EPS 1.90 2.35 -19.15% 3.07 1.92 59.90% 3.81 1.86 104.84% 2.76 1.98 39.39%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 623.43 647.00 527.49 486.65 431.96 306.96 320.66 238.09 206.15 326.22 283.69 Net Sales Growth 8.88% 22.66% 8.39% 12.66% 40.72% -4.27% 34.68% 15.49% -36.81% 14.99% Cost Of Goods Sold 462.71 483.70 399.11 375.48 327.60 228.64 241.48 179.59 149.43 247.00 220.09 Gross Profit 160.72 163.31 128.38 111.16 104.36 78.32 79.19 58.50 56.72 79.23 63.60 GP Margin 25.78% 25.24% 24.34% 22.84% 24.16% 25.51% 24.70% 24.57% 27.51% 24.29% 22.42% Total Expenditure 551.69 571.25 475.68 439.18 386.84 283.73 290.70 219.77 183.46 288.67 252.66 Power & Fuel Cost - 12.37 11.02 8.80 8.66 6.31 4.79 4.09 3.07 3.48 3.22 % Of Sales - 1.91% 2.09% 1.81% 2.00% 2.06% 1.49% 1.72% 1.49% 1.07% 1.14% Employee Cost - 19.39 17.15 15.10 14.29 13.36 10.14 8.90 7.22 6.58 5.62 % Of Sales - 3.00% 3.25% 3.10% 3.31% 4.35% 3.16% 3.74% 3.50% 2.02% 1.98% Manufacturing Exp. - 29.06 23.90 18.30 16.76 14.44 15.03 11.82 12.93 14.54 11.28 % Of Sales - 4.49% 4.53% 3.76% 3.88% 4.70% 4.69% 4.96% 6.27% 4.46% 3.98% General & Admin Exp. - 3.49 2.73 2.25 2.42 1.87 2.45 1.92 1.69 2.03 1.44 % Of Sales - 0.54% 0.52% 0.46% 0.56% 0.61% 0.76% 0.81% 0.82% 0.62% 0.51% Selling & Distn. Exp. - 9.63 9.01 8.63 7.60 6.08 6.61 5.95 5.11 8.25 5.64 % Of Sales - 1.49% 1.71% 1.77% 1.76% 1.98% 2.06% 2.50% 2.48% 2.53% 1.99% Miscellaneous Exp. - 13.61 12.77 10.62 9.51 13.02 10.21 7.49 4.03 6.80 5.64 % Of Sales - 2.10% 2.42% 2.18% 2.20% 4.24% 3.18% 3.15% 1.95% 2.08% 1.89% EBITDA 71.74 75.75 51.81 47.47 45.12 23.23 29.96 18.32 22.69 37.55 31.03 EBITDA Margin 11.51% 11.71% 9.82% 9.75% 10.45% 7.57% 9.34% 7.69% 11.01% 11.51% 10.94% Other Income 12.35 12.10 6.11 5.20 10.54 4.21 4.70 7.38 7.59 3.51 5.05 Interest 0.47 0.96 0.75 1.58 2.03 1.26 0.60 0.45 0.72 0.86 0.95 Depreciation 8.46 8.58 9.70 11.96 15.08 7.03 1.66 1.83 1.97 2.26 3.27 PBT 75.17 78.31 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 31.86 Tax 17.35 18.25 11.29 8.56 10.12 4.85 9.04 6.90 7.54 12.13 9.87 Tax Rate 23.08% 23.30% 23.78% 21.88% 26.25% 25.31% 27.90% 29.46% 27.33% 31.97% 30.98% PAT 57.81 60.06 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 21.99 PAT before Minority Interest 57.81 60.06 36.18 30.56 28.44 14.31 23.37 16.51 20.05 25.80 21.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.27% 9.28% 6.86% 6.28% 6.58% 4.66% 7.29% 6.93% 9.73% 7.91% 7.75% PAT Growth 42.39% 66.00% 18.39% 7.45% 98.74% -38.77% 41.55% -17.66% -22.29% 17.33% EPS 11.54 11.99 7.22 6.10 5.68 2.86 4.66 3.30 4.00 5.15 4.39

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 291.22 241.22 213.77 190.64 162.21 164.60 149.62 140.55 119.28 100.90 Share Capital 25.06 25.06 25.06 25.06 12.53 12.53 12.53 12.53 12.53 4.18 Total Reserves 266.16 216.17 188.72 165.59 149.68 152.07 137.09 128.02 106.75 96.72 Non-Current Liabilities 1.35 1.66 2.50 2.53 1.46 -0.04 -0.20 -0.49 -0.35 -0.09 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.38 1.58 1.54 1.51 1.17 0.87 0.95 0.73 0.78 0.58 Current Liabilities 152.69 161.34 130.91 139.47 162.71 74.80 58.63 47.42 72.48 66.81 Trade Payables 140.50 152.77 121.57 120.02 104.64 58.92 51.98 42.18 52.32 48.01 Other Current Liabilities 10.04 8.50 6.16 5.76 13.31 11.19 2.91 4.05 2.72 2.00 Short Term Borrowings 2.01 0.00 3.11 13.60 44.56 4.39 2.44 0.00 2.11 0.00 Short Term Provisions 0.14 0.07 0.06 0.10 0.20 0.31 1.30 1.19 15.33 16.80 Total Liabilities 445.26 404.22 347.18 332.64 326.38 239.36 208.05 187.48 191.41 167.62 Net Block 48.95 52.81 61.42 71.42 84.04 21.17 16.70 17.33 18.32 9.49 Gross Block 104.15 99.91 99.67 97.93 95.67 26.51 20.48 19.28 33.42 22.62 Accumulated Depreciation 55.20 47.10 38.25 26.51 11.62 5.34 3.78 1.95 15.11 13.13 Non Current Assets 109.06 96.60 88.49 94.91 103.42 87.19 53.87 49.52 40.37 24.06 Capital Work in Progress 0.45 0.00 0.10 0.00 0.00 33.85 5.92 0.26 0.19 0.33 Non Current Investment 41.71 39.68 21.21 20.37 13.70 30.03 30.70 31.13 21.03 13.27 Long Term Loans & Adv. 4.95 4.11 2.20 2.62 2.68 2.13 0.56 0.80 0.84 0.97 Other Non Current Assets 13.00 0.00 3.55 0.50 3.00 0.00 0.00 0.00 0.00 0.00 Current Assets 336.20 307.61 258.69 237.73 222.95 152.18 154.18 137.96 151.04 143.55 Current Investments 55.05 51.15 21.47 11.01 65.86 8.62 35.56 39.26 21.95 29.33 Inventories 75.40 72.64 79.92 81.43 61.49 42.85 31.90 29.82 23.69 16.42 Sundry Debtors 189.95 171.23 135.71 106.86 81.03 74.53 70.92 56.65 74.67 68.15 Cash & Bank 9.67 6.65 15.95 20.09 2.52 11.49 8.00 6.39 13.38 14.15 Other Current Assets 6.12 0.67 1.00 16.80 12.05 14.69 7.78 5.85 17.35 15.50 Short Term Loans & Adv. 5.15 5.27 4.63 1.53 4.73 3.43 1.06 3.90 15.34 13.88 Net Current Assets 183.51 146.28 127.78 98.26 60.25 77.38 95.55 90.55 78.55 76.75 Total Assets 445.26 404.21 347.18 332.64 326.37 239.37 208.05 187.48 191.41 167.61

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 12.93 53.90 28.86 -18.73 48.93 7.12 1.83 26.12 16.50 18.79 PBT 78.31 47.47 39.12 38.55 19.16 32.40 23.42 27.59 37.94 31.86 Adjustment -2.59 3.53 8.17 7.43 8.30 -2.12 -1.88 -4.82 -0.74 -1.41 Changes in Working Capital -43.73 16.37 -9.29 -54.98 26.57 -13.40 -12.57 11.09 -7.96 -0.66 Cash after chg. in Working capital 32.00 67.37 38.00 -9.00 54.03 16.89 8.96 33.86 29.23 29.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.07 -13.47 -9.14 -9.73 -5.09 -9.76 -7.13 -7.73 -12.74 -11.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.92 -43.48 -7.82 52.20 -76.53 2.86 1.89 -20.31 -5.24 -11.86 Net Fixed Assets -4.69 -0.14 -1.84 -2.26 -35.31 -33.96 -6.86 14.07 -10.66 0.92 Net Investments -5.93 -48.15 -11.30 48.18 -40.91 27.61 4.13 -27.41 -0.38 -15.77 Others 11.54 4.81 5.32 6.28 -0.31 9.21 4.62 -6.97 5.80 2.99 Cash from Financing Activity -8.57 -12.29 -19.45 -33.12 22.17 -6.51 -5.12 -3.66 -9.00 -8.30 Net Cash Inflow / Outflow 5.27 -1.87 1.60 0.35 -5.43 3.47 -1.40 2.15 2.25 -1.37 Opening Cash & Equivalents 1.93 3.80 2.20 1.85 7.27 3.80 5.20 3.05 0.80 2.17 Closing Cash & Equivalent 7.20 1.93 3.80 2.20 1.85 7.27 3.80 5.20 3.05 0.80

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 58.11 48.14 42.66 38.04 32.37 32.85 29.86 28.05 23.80 20.13 ROA 14.14% 9.63% 8.99% 8.63% 5.06% 10.44% 8.35% 10.58% 14.37% 13.29% ROE 22.56% 15.90% 15.11% 16.12% 8.75% 14.87% 11.38% 15.43% 23.44% 23.55% ROCE 29.66% 21.05% 19.33% 19.75% 10.87% 20.56% 16.31% 21.61% 34.91% 35.13% Fixed Asset Turnover 6.37 5.31 4.97 4.55 5.20 13.71 12.23 8.23 12.19 13.02 Receivable days 101.36 105.71 90.17 77.87 89.32 82.39 95.73 110.46 76.28 86.54 Inventory Days 41.55 52.54 59.98 59.23 59.91 42.34 46.32 45.01 21.42 21.65 Payable days 110.65 125.45 117.42 125.15 102.62 71.01 80.06 97.41 64.25 79.63 Cash Conversion Cycle 32.26 32.80 32.72 11.94 46.61 53.72 61.99 58.06 33.45 28.56 Total Debt/Equity 0.01 0.00 0.01 0.07 0.27 0.03 0.02 0.00 0.02 0.00 Interest Cover 82.82 64.61 25.76 19.99 16.23 55.16 52.91 39.30 44.87 34.69

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Anuh Pharma - Quarterly Results
9th Aug 2024, 18:06 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback